Patents by Inventor Jonathan Yingling

Jonathan Yingling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080027102
    Abstract: A compound according to formula II and the pharmaceutically acceptable salts thereof and the method of treating cancer in a patient in need thereof by administration of said compound.
    Type: Application
    Filed: July 25, 2007
    Publication date: January 31, 2008
    Inventors: Douglas Beight, Jason Sawyer, Jonathan Yingling
  • Publication number: 20060040983
    Abstract: A compound according to formula II and the pharmaceutically acceptable salts thereof and the method of treating cancer in a patient in need thereof by administration of said compound.
    Type: Application
    Filed: November 10, 2003
    Publication date: February 23, 2006
    Applicant: Eli Lilly and Company
    Inventors: Douglas Beight, Jason Sawyer, Jonathan Yingling
  • Publication number: 20050222197
    Abstract: Novel pyrazolopyridine derivative compounds are disclosed and their use as pharmaceutical agents, in particular their use as TGF-beta signal transduction inhibitors useful in the treatment of cancer and other disease states influenced by TGF beta.
    Type: Application
    Filed: September 16, 2003
    Publication date: October 6, 2005
    Inventors: Douglas Beight, Rosanne Bonjouklian, Junkai Liao, William McMillen, Brandon Parkhurst, Jason Sawyer, Jonathan Yingling, Jeremy York